Skip to main content
. 2022 Sep 20;13:937900. doi: 10.3389/fimmu.2022.937900

Figure 3.

Figure 3

(A)The number of stem cell products not infused decreased significantly in the first quarter (March 2020 to July 2020) versus the later quarter of the pandemic (March 2021 to July 2021). (B) Decline in the number of products not infused was most pronounced in domestic transplant centers. Data collected included donor collection and infusion dates from March 2020 through 29 July 2021. This timeframe was split into two time periods for COVID-19 comparison, comparing the first 5 months (March 20–July20) of the pandemic to the last 5 months (March 21–July 21). Kruskal–Wallis tests were performed to test the impact COVID-19 had on products infused. p < 0.05 is significant.